Cell and Gene Therapies (CGT) have unlimited potential as treatment options for unmet medical needs. Dr. Miguel Forte (MD, PhD), the current President of the International Society for Cell and Gene Therapy (ISCT) and a global serial entrepreneur, and Dr. Tsung-Yen Wu, an entrepreneur in residence at AdBio Partners, will share their insights about the rising potential and opportunities of CGT in Taiwan, Japan, and East Asia's business momentum in life science. With confidence in Taiwan's upcoming success in building a vigorous healthcare ecosystem, comparable to its strength in the semiconductor industry, they will share their visions as well as funding and collaborative opportunities and strategies with top-notch scientists and key players in the life science ecosystem for CGT in Taiwan. We welcome your participation.
Registration website: https://forms.gle/m4TVwJXwCRsbR89SA
Transportation information: https://nbrp.sinica.edu.tw/pages/41
